4//SEC Filing
Robichaud Albert 4
Accession 0001562180-23-001425
CIK 0001597553other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:47 PM ET
Size
7.7 KB
Accession
0001562180-23-001425
Insider Transaction Report
Form 4
Robichaud Albert
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-13+16,720→ 16,720 totalExercise: $45.28Exp: 2033-02-13→ Common Stock (16,720 underlying)
Footnotes (1)
- [F1]The securities awarded on February 13, 2023 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 4,180 shares of common stock shall vest on the one year anniversary of February 13, 2023, with 12,540 shares vesting in 36 equal monthly installments thereafter.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001612861
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:47 PM ET
- Size
- 7.7 KB